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In Indonesia in the year of 2016, there were 
34.5 million adults living with HIV infection 
from the total of 36.7 million people of all ages 
living with the infection. New HIV infection 
cases declined from the estimated 1.9 million 
(11%) in 2010 to 1.6 million in 2016.1 Since 
2013, the Indonesian government had adopted 
the national strategy to increase access to 
antiretroviral therapy as its role to stop HIV 
transmission. Early testing and initiation of 
antiretroviral therapy among key population 
group such as pregnant women, serodiscordant 
couple, patient with tuberculosis or hepatitis B 
co-infection, etc were widely applied under the 
regulation of the ministry of health.2 Parallel to 
that, many cities across Indonesia are showing 
the effort in increasing the access to condom 
that showed an effective impact in lowering the 
number of sexually transmitted infection such as 
Syphilis in Indonesia from 2014 report.3
Initial report by Nelwan EJ et.al,4 showed 
that among the high risk group such as prisoners, 
the Indonesian government has already applied 
the regulation for HIV screening at the time of 
admission,5 which lead to significantly lower 
number of HIV infection among tested prisoner.4 
In a larger scale, such as in population, the question 
is what kind of preventive measures proved to 
be effective, particularly for the Indonesian 
government to best allocate available funding. 
In this edition, a very exciting information was 
gathered from a study conducted by Verstraeten6 
and colleagues in Bandung which is the most 
HIV prevalent city in West Java, regarding the 
four different intervention programs of HIV 
transmission, including condom distribution, 
mobile HIV testing (VCT), religious based IEC 
and STI services, which were the most cost 
effective measures to be applied and information 
its challenges.
On the other hand, the Indonesian government 
reported that 31% of people diagnosed with 
HIV was already on antiretroviral treatment.7 
In clinical setting, HIV patient will receive 
antiretroviral treatment based on the WHO 
criteria that includes clinical criteria (HIV stage 
3 and 4) and laboratory criteria (CD4 below 350 
cell/uL in regards of viral load level).2,8 In spite 
of the poor access to antiretroviral treatment, 
which covers only 6-8% of those who are 
eligible to be treated; nowadays, the concern 
is towards the HIV resistance among treated 
HIV patients in Indonesia which is starting to 
rise.9 In this edition, Yunifiar, et al10 reported the 
epidemiology of HIV infection in Papua which 
is the most HIV prevalent province in Indonesia. 
They also reported the data on HIV subtyping 
and potential HIV drug resistance mutation 
among patients treated in Paniai, Papua.
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